Health
BioNTech, Pfizer file for EU approval of COVID-19 vaccine – CGTN
On Tuesday, Germany’s BioNTech and its U.S. partner Pfizer said they had applied for EU regulatory approval for their COVID-19 vaccine, raising hopes that the first jabs could be administered in December.
The two companies said in a statement that they had submitted an application to the European Medicines Agency on Monday “for Conditional Marketing Authorization (CMA)” for their vaccine after tests showed it was 95 percent effective against the novel coronavirus.
If approved, the jab could potentially…
-
Business22 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?
-
Noosa News8 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
General22 hours agoTop chess player Magnus Carlsen forced into draw in historic game against over 134,000 people
-
General22 hours agoTaiwan’s President Lai Ching-te calls for peace and dialogue with China while also calling for defence boosts